Weight
Down 14.2 lb
−7.2% since Jan 21
Current dose
0.5 mg weekly
Wednesdays · set by your clinician
Next refill
Oct 28
Ships Oct 22 · on schedule
Check-in
in 3 days
Sat, Oct 24 · Dr. Okafor
Weight trend
Morning weigh-ins, one point per week
Jan 21Oct 21
Dose schedule
Weekly, on Wednesdays
19
20
21Today
22
23
24Check-in
25
26
27
28Refill
29
30
31
1
Dose day
Today
Dose changes are decided by your licensed clinician.
Refill tracker
Next refill Oct 28 · Partner pharmacy
- PrescribedOct 14 · Dr. Okafor
- PharmacyOct 15 · Filled
- ShippedShips Oct 22 · packing
- DeliveredExpected by Oct 26
Refills are reviewed by your clinician before they ship.
Messages with Dr. Maya Okafor MD
Dr. Maya Okafor MD Obesity medicine · usually replies within one business dayMorning, Jordan. Your weight trend is steady. How have the last two weeks felt on 0.5 mg?
Dr. Okafor · Mon 9:14
Nausea was mild the first two days, then it settled. Smaller lunches helped.
You · Mon 9:40
Good to hear. Keep logging your morning weight on the same day each week. We will go over it at your check-in on Saturday.
Dr. Okafor · Mon 9:52
If you get severe stomach pain or vomiting that will not stop, call your local emergency number.
Dr. Okafor · Mon 9:53
Sample thread. Messages you add appear on this screen only.
Labs
Drawn Sep 2 · Partner lab
| Test | Result | Status |
|---|---|---|
| HbA1c | 5.4%Reference under 5.7% | In range |
| Fasting glucose | 92 mg/dLReference 70 to 99 | In range |
| Lipids, LDL | 118 mg/dLReference under 100 | Watch |
| TSH | 2.1 mIU/LReference 0.4 to 4.0 | In range |
Watch means the result sits above the reference target. Your clinician will review it at check-in.
Today
Steady beats fast. We will change your dose only when your numbers ask us to.
Account
Sample account details
- Name
- Jordan
- Plan
- Weight Care, $249/mo
- Care team
- Dr. Maya Okafor MD, Lena Brandt NP
- Pharmacy
- Partner pharmacy
- Data
- Sample data
Important Safety Information
Boxed warning: risk of thyroid C-cell tumors. In rodent studies, GLP-1 medicines caused thyroid C-cell tumors. It is unknown whether they cause thyroid C-cell tumors, including medullary thyroid carcinoma (MTC), in people. Do not use if you or a family member has had MTC, or if you have Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). Tell your clinician about a lump or swelling in your neck, trouble swallowing, shortness of breath, or persistent hoarseness.
Common side effects include nausea, diarrhea, vomiting, constipation, stomach pain, and headache.
Serious side effects can include pancreatitis, gallbladder problems, low blood sugar (hypoglycemia, which is more likely with insulin or sulfonylureas), and kidney problems. Seek care right away for severe or persistent stomach pain.
This medication is not for use during pregnancy.
Results vary from person to person. A licensed clinician decides whether this treatment is right for you.